Nachrichten zur Merck & Co. Inc. Aktie

Why Summit Therapeutics Stock Is Jumping Today

Shares of Summit Therapeutics (NASDAQ: SMMT) had jumped 14.3% at 11:31 a.m. ET on Tuesday. The nice gain came after…

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (DJINDICES: ^DJI) had…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Merck KGaA nach einer Medizinkonferenz mit einem Kursziel…

Earnings Season Scorecard and Fresh Analyst Reports for Chevron, Merck & Others

Todays Research Daily features a real-time update on the Q4 earnings season and fresh Chevron (CVX), Merck (MRK), QUALCOMM (QCOM),…

Is Moderna Stock a Buy?

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index.…

Exclusive-Kennedy played key role in vaccine case against Merck By Reuters

Exclusive-Kennedy played key role in vaccine case against Merck…

Merck & Co Aktie: Kursziel gekappt

New York (www.aktiencheck.de) - Rating-Update: Vamil Divan, Analyst von Guggenheim Securities, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055,…

Merck Aktie: Erfolgswelle schwappt weiter!

Die Merck-Aktie zeigte am heutigen Handelstag eine volatile Entwicklung an der XETRA-Börse. Der Anteilsschein bewegte sich in einer Spanne zwischen…

This Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income

The technology sector has crushed the S&P 500 over the past three, five, and 10 years as leading tech stocks…

JPMorgan belässt Merck KGaA auf Overweight - Ziel 190 Euro

NEW YORK (dpa-AFX Analyser) - JPMorgan hat die Einstufung für Merck KGaA nach einer Fachkonferenz der US-Bank mit einem Kursziel…

Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?

We believe investors with a long-term horizon should hold MRK stock, while short-term investors should consider selling it.…

Antibody Drug Conjugates Market Outlook 2025-2035, with Forecasts for Payload Type, Linker Type, Target Antigen and Applications

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report 2025-2035" has been added to…

Jim Cramer says he supports healthcare stocks for their long-term value

CNBCs Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.…

Merck CEO talks medicines beyond the companys top cancer drug

Merck CEO Rob Davis told CNBCs Jim Cramer that theres more to the pharmaceutical giant than its lucrative cancer drug,…

Merck & Co. Inc. (MRK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

…

Digital Neuro Biomarkers Market Research 2025-2030, Competitive Analysis of Altoida, Koneksa, Biogen, Roche, NeuraMetrix, Merck, Linus Health, Neurotrack Technologies, Huma, and NeuraLight

The market is witnessing significant growth owing to various factors such as increased prevalence of neurological disorders, rising geriatric population…

Meet the 15 Dow Jones Stocks That Combined for Over $150 Billion in Dividends in 2024 and Will All Likely Boost Their Payouts Again in 2025

The Dow Jones Industrial Average (DJINDICES: ^DJI) is composed of 30 industry-leading blue-chip businesses that represent the broader market. Many…

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer

The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…

Merck & Co Aktie: UBS skeptisch für BioPharma-Markt 2025 - Der Pharma-Riese trotzdem mit Potenzial

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der UBS: Aktuelle Bewertung Der UBS-Analyst, Trung Huynh, hat das Kursziel für Merck & Co…

Pfizer, Astellas win China nod for Padcev in bladder cancer with Merck’s Keytruda

…

Merck Aktie: Stabiles Wachstum zu fairem Preis

Wien (www.aktiencheck.de) - Merck-Aktienanalyse der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), rät in einer…

Merck führt erste cyber-physische Digital-Trust-Plattform für höhere Produktsicherheit und Schutz vor Produktfälschung am Markt ein

Merck: Darmstadt, Deutschland (ots/PRNewswire) - - Sichere cyber-physische Plattform M-Trust™ für vertrauenswürdigen digitalen Datenaustausch ermöglicht Erstellung digitaler Zwillinge zur Erhöhung…

Merck to buy vaccine plant from WuXi Biologics: report

…

Why Viking Therapeutics Stock Plummeted by 24% in December

Viking Therapeutics (NASDAQ: VKTX) didnt exactly capture investors hearts in the final month of 2024. The biotech companys share price…

Prediction: These 3 Healthcare Stocks Will Soar in 2025

No one knows for sure what the new year will hold for the market. However, some stocks chances for success…

Should You Buy the Dip on This High-Flying Stock?

Its been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Thanks to impressive mid-stage clinical results,…

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock…

Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks.

Investing in dividend stocks can be an excellent way to boost your income each year. But the challenge can be…

2 High-Yield Dividend Stocks to Buy Early in 2025

The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb…

Will This Major Pharmaceutical Stock Announce a Stock Split in 2025?

Stocks splits have been a huge market theme in 2024, with big names across industries, from technology giant Nvidia to…

3 Stocks That Could Be Monster Winners in 2025

What do many kids like most about the coming of a new year? The fireworks. Investors dont mind seeing some…

These stocks will be the biggest Dow winners of 2025, according to analysts

Some favorites of the Dow Jones Industrial Average, including Nvidia and Merck, could surge next year.…

2 Reasons to Sell Merck Stock and 1 Reason to Buy

There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner…

Merck - Selten so attraktiv

Mit strategischen Zukäufen treibt die deutsche Merck ihr geplantes Wachstum zielgerichtet voran. Die Anleger zeigen sich zuletzt aber skeptisch -…

Is Merck the Next Big Weight-Loss Stock?

Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the…

Is Recursion Pharmaceuticals Stock a Millionaire Maker?

Successfully navigating the stock market requires patience and a long-term perspective. The key is sticking to a consistent plan and…

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck?

The weight-loss biotech Viking Therapeutics (NASDAQ: VKTX) saw its stock get absolutely slammed on Dec. 18, falling 18% as a…

Merck Aktie: Aussichten trüb

Die Merck KGaA verzeichnet in den letzten Handelstagen des Jahres 2024 eine deutliche Abwärtsbewegung an der Frankfurter Börse. Der Pharma-…

Why Viking Therapeutics Tumbled by More Than 10% This Week

News of a fresh licensing deal by a well-capitalized rival sent Viking Therapeutics (NASDAQ: VKTX) stock into something of a…

BMO cuts rating on Merck and Biogen, on lack of near term catalyst By Investing.com

BMO cuts rating on Merck and Biogen, on lack of near term catalyst…

Investing in Merck (NYSE:MRK) three years ago would have delivered you a 43% gain

It hasnt been the best quarter for Merck & Co., Inc. ( NYSE:MRK ) shareholders, since the share price has…

Want to Collect a Dividend Every Month? Invest in These 3 High-Yielding Income Stocks

Collecting dividend income on a recurring basis can help strengthen your financial position and be a way for you to…

Is Moderna Stock a Buy?

Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…

Where Will Summit Therapeutics Be in 5 Years?

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab,…

3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…

MRKs Pivotal Study on Two-Drug, Once-Daily HIV Pill Meets Goals

Merck posts positive data from two phase III studies evaluating a two-drug, single-tablet regimen of doravirine/islatravir in adults with HIV-1…

Mercks HIV treatment meets main goal of two late-stage studies By Reuters

Mercks HIV treatment meets main goal of two late-stage studies…

Merck Enters Obesity Space, Buys Rights to Hansohs Oral GLP-1 Drug

Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh Pharma.…

Opening Bell: Dow Jones steigt vor Zinsentscheid; Nvidia, Rigetti, IBM, D-Wave, Merck, Unitedhealth im Fokus

Am US-Aktienmarkt zeichnen sich am Mittwoch zum Handelsstart moderate Gewinne ab. Im Fokus steht die Leitzinsentscheidung zwei Stunden vor Börsenschluss…

Pharmaindustrie: Merck sichert sich Rechte an Abnehmpille in Milliardendeal

Der Pharmakonzern hat eine Lizenzvereinbarung mit dem chinesischem Biotech-Unternehmen Hansoh geschlossen. Merck darf künftig die Abnehmpille der Chinesen vermarkten und…